Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

STXS stock hub

Stereotaxis, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STXSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

185.2M

NYSEAMERICAN

Market data

Live price

Current market quote for this ticker.

Current price

STXS

In the news

Latest news · STXS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-143.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-59.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STXS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

212

Groups with data

Currency

USD

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001289340
Company name	Stereotaxis, Inc.
Country	United States
Country code	US
Cusip	85916J409
Employees	131
Employees Change	-8%
Employees Change Percent	-5.76
Enterprise value	$177.2M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
IPO Date	2004-08-12
Isin	US85916J4094
Last refreshed	2026-05-10
Market cap	$185.2M
Market cap category	Micro-Cap
Price	$1.9
Price currency	USD
Rev Per Employee	247,152.67x
Sector	Healthcare
Sic	3845
Symbol	STXS
Website	https://www.stereotaxis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.37%
EV Sales Forward	4.27x
EV/Sales	5.47x
FCF yield	-7.44%
P/B ratio	13.44x
P/S ratio	5.72x
PS Forward	4.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-61.59%
EBITDA Margin	-56.79%
Gross margin	52.73%
Gross Profit	$17.1M
Gross Profit Growth	16.97%
Gross Profit Growth Q	34.55%
Gross Profit Growth3 Y	-2.59%
Gross Profit Growth5 Y	-2.08%
Net Income	$-22.9M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-66.85%
Profit Margin	-66.85%
Profit Per Employee	$-174,916
ROA	-25.18
Roa5y	-23.96
ROCE	-66.71
ROE	-143.6
Roe5y	-88.57
ROIC	-59.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.19%
Cagr15y	-17.08%
Cagr1y	-9.1%
Cagr20y	-18.23%
Cagr3y	1.26%
Cagr5y	-22.28%
EPS Growth Quarters	3
EPS Growth Years	1
Revenue Growth	20.28x
Revenue Growth Q	36.31x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	4.78x
Revenue Growth5 Y	3.99x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.65
Assets	$52.3M
Cash	$13.4M
Current Assets	$33.8M
Current Liabilities	$22.4M
Debt	$5.4M
Debt Equity	$0.29
Equity	$18.7M
Liabilities	$33.5M
Long Term Assets	$18.4M
Long Term Liabilities	$11.2M
Net Cash	$8M
Net Cash By Market Cap	$4.31
Net Cash Growth	28.56%
Net Debt Equity	$-0.43
Tangible Book Value	$3.3M
Tangible Book Value Per Share	$0.03
WACC	11.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.51
Inventory Turnover	1.71
Net Working Capital	$-1.3M
Quick ratio	1.05
Working Capital	$11.5M
Working Capital Turnover	$3.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.78%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	24.18%
1Y total return	-9.09%
200-day SMA	2.43
3Y total return	3.83%
50-day SMA	1.93
50-day SMA vs 200-day SMA	50under200
5Y total return	-71.64%
All Time High	168.8
All Time High Change	-98.87%
All Time High Date	2007-10-29
All Time Low	0.47
All Time Low Change	304.26%
All Time Low Date	2016-11-15
ATR	0.09
Beta	1.33
Beta1y	1.19
Beta2y	0.8
Ch YTD	-17.39
High	1.92
High52	3.59
High52 Date	2025-10-09
High52ch	-47.08%
Low	1.85
Low52	1.74
Low52 Date	2026-03-19
Low52ch	9.2%
Ma50ch	-1.66%
Price vs 200-day SMA	-21.81%
RSI	47.53
RSI Monthly	43.72
RSI Weekly	40.44
Sharpe ratio	0.03x
Sortino ratio	0.15
Total Return	-6.78%
Tr YTD	-17.39
Tr15y	-93.97%
Tr1m	2.7%
Tr1w	-1.55%
Tr3m	-6.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.05
Earnings Revenue Estimate	8,620,000x
Earnings Revenue Estimate Growth	15.36x
Operating Income	$-19.9M
Operating margin	-61.59
Price target	$4
Price Target Change	$111

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	68,815,882%
Float Percent	70.6%
Shares Insiders	12.21%
Shares Institutions	30.88%
Shares Out	97,477,538
Shares Qo Q	4.3%
Shares Yo Y	6.78%
Short Float	4.84%
Short Ratio	8.14
Short Shares	3.42

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-23.6M
Average Volume	405,041.2x
Bv Per Share	0.14
CAPEX	$-93,000
Ch10y	24.18
Ch15y	-94.35
Ch1m	2.7
Ch1w	-1.55
Ch1y	-9.09
Ch20y	-98.32
Ch3m	-6.4
Ch3y	3.83
Ch5y	-71.64
Ch6m	-30.15
Change	0%
Change From Open	0
Close	1.9
Days Gap	0
Depreciation Amortization	1,555,000
Dollar Volume	627,541.5
Earnings Date	2026-05-12
Earnings Time	amc
EBIT	$-19.9M
EBITDA	$-18.4M
EPS	$-0.25
F Score	3
FCF	$-13.8M
FCF EV Yield	-7.77x
FCF Per Share	$-0.14
Financing CF	14,763,000
Fiscal Year End	December
Founded	1,990
Goodwill	3,764,000
Investing CF	-93,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-09
Last Report Date	2025-12-31
Last Split Date	2012-07-11
Last Split Type	Reverse
Last10k Filing Date	2026-03-12
Ma150	2.33
Ma150ch	-18.52%
Ma20	1.93
Ma20ch	-1.76%
Net CF	985,000
Next Earnings Date	2026-05-12
Open	1.9
Optionable	Yes
Position In Range	71.43
Ppne	7,931,000
Price Date	2026-05-08
Ptbv Ratio	56.33
Relative Volume	0.82x
Revenue	32,377,000x
SBC By Revenue	30.43x
Share Based Comp	9,852,000
Tr20y	-98.21%
Tr6m	-30.15%
Us State	Missouri
Volume	330,285
Z Score	-12.26

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STXS pay a dividend?

Capital-return profile for this ticker.

Performance

STXS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STXS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+30.9%

Float: +70.6% of shares outstanding

Insider ownership

+12.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

STXS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.5

Neutral momentum band

Price vs 200-day MA

-21.8%

50/200-day relationship not available

Beta (5Y)

1.33

More volatile than the market

Sharpe ratio

0.03

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STXS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current STXS stock rating?

Stereotaxis, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full STXS analysis?

The full report lives at /stocks/STXS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for STXS?

The latest report frames STXS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the STXS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.